ConductScience.org, home

Paper41594658

Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells.

Bao R and 2 others. Biomolecules, 2026. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells. Papers, record 41594658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41594658

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells.
PubMed
Journal
Biomolecules
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
4.57, provisional
iCite
Revised in PubMed
2026-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bao RRongrong
2Wang TTianrui
3Jiang WWenkaihttps://orcid.org/0000-0002-2143-8680

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ResveratrolMajor topic
NeoplasmsMajor topic
Antineoplastic Agents, PhytogenicMajor topic
Humans
Animals
Tumor Microenvironment
Metabolic Reprogramming
Glycolysis
Macrophages

Source PubMed

Download CSV of topics

References163

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138649722Cancer cell metabolism and antitumour immunity.Nat Rev Immunol2024https://conductscience.org/library/papers/38649722PubMed
234027036The PIDDosome: centrosome guardian and backup on the DNA damage response.Mol Cell Oncol2021https://conductscience.org/library/papers/34027036PubMed
332849616Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.Front Immunol2020https://conductscience.org/library/papers/32849616PubMed
439761424Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content.Gut Microbes2025https://conductscience.org/library/papers/39761424PubMed
534859370Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer.Clin Transl Oncol2022https://conductscience.org/library/papers/34859370PubMed
640917691Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/40917691PubMed
726321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed
837836529Cancer Metabolism as a Therapeutic Target and Review of Interventions.Nutrients2023https://conductscience.org/library/papers/37836529PubMed
936430164Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review.Int J Mol Sci2022https://conductscience.org/library/papers/36430164PubMed
1036091247Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment.Front Nutr2022https://conductscience.org/library/papers/36091247PubMed
1132937636In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation.J Innate Immun2021https://conductscience.org/library/papers/32937636PubMed
1235056739Resveratrol and Immune Cells: A Link to Improve Human Health.Molecules2022https://conductscience.org/library/papers/35056739PubMed
1334052324Resveratrol for cancer therapy: Challenges and future perspectives.Cancer Lett2021https://conductscience.org/library/papers/34052324PubMed
1438685033CD8+ T cell-based cancer immunotherapy.J Transl Med2024https://conductscience.org/library/papers/38685033PubMed
1540141030Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections.Int J Mol Sci2025https://conductscience.org/library/papers/40141030PubMed
1631478911Killers 2.0: NK cell therapies at the forefront of cancer control.J Clin Invest2019https://conductscience.org/library/papers/31478911PubMed
1736768924Modulating Glycolysis to Improve Cancer Therapy.Int J Mol Sci2023https://conductscience.org/library/papers/36768924PubMed
1832934330Exploring the NK cell platform for cancer immunotherapy.Nat Rev Clin Oncol2021https://conductscience.org/library/papers/32934330PubMed
1930808985Immunometabolism and natural killer cell responses.Nat Rev Immunol2019https://conductscience.org/library/papers/30808985PubMed
2036800999Spatial profiling technologies illuminate the tumor microenvironment.Cancer Cell2023https://conductscience.org/library/papers/36800999PubMed

See all 163 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42877341Resveratrol-Loaded Responsive Core-Shell Tecto Dendrimers Potentiate Hepatocellular Carcinoma Therapy.Biomater Res2026https://conductscience.org/library/papers/42877341PubMed
42654091Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin.Pharmaceutics2026https://conductscience.org/library/papers/42654091PubMed
42358819Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities.Oncol Res2026https://conductscience.org/library/papers/42358819PubMed
42196257Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42196257PubMed
41977169Resveratrol as a Modulator of Adriamycin-, Taxol-, and Cisplatin-Induced Cytotoxicity in MCF-7 Breast Cancer Cells.Int J Mol Sci2026https://conductscience.org/library/papers/41977169PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41594658

GET https://conductscience.org/api/papers/v1/41594658/references?page=2